Mankind Pharma (BOM:543904) Cash-to-Debt : N/A (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Mankind Pharma's cash to debt ratio for the quarter that ended in Dec. 2023 was N/A.

The historical rank and industry rank for Mankind Pharma's Cash-to-Debt or its related term are showing as below:

BOM:543904' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.47 Med: 8.29 Max: 13.11
Current: 13.11

During the past 3 years, Mankind Pharma's highest Cash to Debt Ratio was 13.11. The lowest was 1.47. And the median was 8.29.

BOM:543904's Cash-to-Debt is ranked better than
78.99% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs BOM:543904: 13.11

Mankind Pharma Cash-to-Debt Historical Data

The historical data trend for Mankind Pharma's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Mankind Pharma Cash-to-Debt Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Cash-to-Debt

8.29

8.33

1.47

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial					N/A	6.53	N/A	13.11	N/A

Competitive Comparison of Mankind Pharma's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mankind Pharma's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Cash-to-Debt falls into.

Mankind Pharma Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Mankind Pharma's Cash to Debt Ratio for the fiscal year that ended in Mar. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12793.09	/	(8208.91	+	521.84)
	=	1.47

Mankind Pharma's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Mankind Pharma (BOM:543904) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Mankind Pharma Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Cash-to-Debt

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines